Search - tctmd.com

Displaying 21 - 40 of 52

Sort: Relevancy | Date

News Daily News

June 2020 News Roundup

L.A. McKeown

June 01, 2020

News Daily News

Study Challenges Link Between PCI Volumes and TAVR, TMVr Outcomes

Todd Neale

February 18, 2020

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Shelley Wood

March 11, 2019

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

News Daily News

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

Michael O'Riordan

September 12, 2018

News Daily News

Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge

Michael O'Riordan

August 08, 2018

News Conference News ACC 2018

ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins

Shelley Wood

March 10, 2018

News Conference News CRT 2018

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Michael O'Riordan

March 05, 2018

News Daily News

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Michael O'Riordan

January 26, 2018

News Conference News ESC 2017

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

Yael L. Maxwell

September 01, 2017

News Conference News ESC 2017

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Shelley Wood

August 27, 2017

News Daily News

TAVR in the US: Regional Variations in Numbers, Outcomes

Michael O'Riordan

August 22, 2017

News Daily News

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Michael O'Riordan

June 26, 2017

News Daily News

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Michael O'Riordan

June 06, 2017

News Conference News EuroPCR 2017

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

Michael O'Riordan

May 17, 2017

News Conference News ACC 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Michael O'Riordan

March 19, 2017

News Conference News CRT 2017

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Michael O'Riordan

February 22, 2017

News Daily News

Early Clinical Outcomes With Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve

Michael O'Riordan

February 09, 2017

News Daily News

大规模 Meta 分析显示，TAVR 与手术 30 天和 1 年死亡率相当

Michael O'Riordan

June 07, 2016

Advertisement

June 2020 News Roundup

Study Challenges Link Between PCI Volumes and TAVR, TMVr Outcomes

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge

ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

TAVR in the US: Regional Variations in Numbers, Outcomes

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Early Clinical Outcomes With Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve

大规模 Meta 分析显示，TAVR 与手术 30 天和 1 年死亡率相当

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content